| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/25/2023 | 17.13% | DA Davidson | $62 → $53 | Maintains | Neutral |
| 04/26/2023 | 23.76% | DA Davidson | $52.5 → $56 | Maintains | Neutral |
| 02/13/2023 | 16.02% | DA Davidson | $49 → $52.5 | Maintains | Neutral |
| 10/27/2022 | 8.29% | DA Davidson | $57 → $49 | Maintains | Neutral |
| 07/28/2022 | 25.97% | DA Davidson | $58 → $57 | Maintains | Neutral |
| 07/12/2022 | 28.18% | DA Davidson | $76 → $58 | Maintains | Neutral |
| 07/07/2022 | 17.13% | Jefferies | $78 → $53 | Downgrades | Hold → Underperform |
| 04/27/2022 | 67.96% | DA Davidson | $86 → $76 | Maintains | Neutral |
| 04/14/2022 | 90.06% | DA Davidson | → $86 | Initiates Coverage On | → Neutral |
| 02/10/2021 | 178.45% | Roth Capital | $107 → $126 | Maintains | Buy |
| 12/17/2020 | 136.46% | Roth Capital | → $107 | Initiates Coverage On | → Buy |
| 08/22/2019 | 43.65% | Jefferies | → $65 | Initiates Coverage On | → Hold |
| 07/03/2019 | 54.7% | Sidoti & Co. | $108 → $70 | Downgrades | Buy → Neutral |
| 04/16/2019 | — | Tigress Financial | Initiates Coverage On | → Buy |
What is the target price for Usana Health Sciences (USNA)?
The latest price target for Usana Health Sciences (NYSE: USNA) was reported by DA Davidson on October 25, 2023. The analyst firm set a price target for $53.00 expecting USNA to rise to within 12 months (a possible 17.13% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Usana Health Sciences (USNA)?
The latest analyst rating for Usana Health Sciences (NYSE: USNA) was provided by DA Davidson, and Usana Health Sciences maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Usana Health Sciences (USNA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Usana Health Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Usana Health Sciences was filed on October 25, 2023 so you should expect the next rating to be made available sometime around October 25, 2024.
Is the Analyst Rating Usana Health Sciences (USNA) correct?
While ratings are subjective and will change, the latest Usana Health Sciences (USNA) rating was a maintained with a price target of $62.00 to $53.00. The current price Usana Health Sciences (USNA) is trading at is $45.25, which is out of the analyst's predicted range.
